Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis

doi:10.4239/wjd.v14.i10.1573

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4026)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

WORD

HTML

1970

Figures (1-3)

359

Sum=2456

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

242

Download

598

Sum=840

Publishing Process of This Article

Item

Count

Browse

165

Download

407

Sum=572

Oct 15, 2023 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Diabetes. Oct 15, 2023; 14(10): 1573-1584
Published online Oct 15, 2023. doi: 10.4239/wjd.v14.i10.1573

Full Size Figure Download Figure

Figure 1 Flow chart of this indirect meta-analysis.

Citation: Lin C, Li ZL, Cai XL, Hu SY, Lv F, Yang WJ, Ji LN. Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis. World J Diabetes 2023; 14(10): 1573-1584
URL: https://www.wjgnet.com/1948-9358/full/v14/i10/1573.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i10.1573